← Portfolio
SingleCell Biotechnology
Cutting edge single cell cancer diagnostics empowered with machine-learning for drug discovery.
All Access
Our SCI-AP Platform of High-Density Single-Cell Assays redefines cancer stem cell analysis by integrating unparalleled single-cell data across all three cancer stem cell states. Powered by machine learning (ML), the platform delivers the most accurate and rapid analysis of cancer stem cells available. Utilizing proprietary protocols and custom plates compatible with high-throughput imagers, the system automates data analysis for faster, deeper insights than traditional methods.
- Sector
- Pharmaceuticals & Medicine, Medical Devices, Biotech
- Based in
- Dallas
- Founded
- 2022
- Team
- 5
- Backed by
- All Access